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The vault particle, with a molecular weight of about 10 MDa,
is the largest ribonucleoprotein that has been described. The
X-ray structure of intact rat vault has been solved at a
resolution of 3.5 A˚ [Tanaka et al. (2009), Science, 323, 384–
388], showing an overall barrel-shaped architecture organized
into two identical moieties, each consisting of 39 copies of
the major vault protein (MVP). The model deposited in the
PDB includes 39 MVP copies (half a vault) in the crystal
asymmetric unit. A 2.1 A˚ resolution structure of the seven
N-terminal repeats (R1–7) of MVP has also been determined
[Querol-Audı´ et al. (2009), EMBO J. 28, 3450–3457], revealing
important discrepancies with respect to the MVP models for
repeats R1 and R2. Here, the re-refinement of the vault
structure by incorporating the high-resolution information
available for the R1–7 domains, using the deformable elastic
network (DEN) approach and maintaining strict 39-fold
noncrystallographic symmetry is reported. The new refine-
ment indicates that at the resolution presently available the
MVP shell can be described well as only one independent
subunit organized with perfect D39 molecular symmetry. This
refinement reveals that significant rearrangements occur in the
N-terminus of MVP during the closing of the two vault halves
and that the 39-fold symmetry breaks in the cap region. These
results reflect the highly dynamic nature of the vault structure
and represent a necessary step towards a better understanding
of the biology and regulation of this particle.
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1. Introduction
The vault complex, with overall dimensions of 40  40 
70 nm and a mass of 10 MDa (Tanaka & Tsukihara, 2012), is
the largest ribonucleoprotein particle that has been found in
eukaryotes (Kedersha et al., 1990; Hamill & Suprenant, 1997;
Herrmann et al., 1997). The main component of vaults is the
100 kDa major vault protein (MVP; Kedersha & Rome, 1986),
whereas the two minor vault proteins comprise the 193 kDa
vault poly(ADP-ribose) polymerase (VPARP; Kickhoefer,
Siva et al., 1999) and the 240 kDa telomerase-associated
protein-1 (TEP1; Kickhoefer, Stephen et al., 1999). Small
untranslated RNAs (vRNAs), the number of which varies
among species, are also found as constitutive components
(Kickhoefer et al., 1993; Stadler et al., 2009). Vaults have been
associated with intrinsic drug resistance (Scheffer et al., 1995),
but have also been related to nucleocytoplasmatic transport,
cell signalling and innate immunity (Berger et al., 2009;
Kowalski et al., 2007). As MVP knockdown results in disrup-
tion of the lysosomal compartment, it has been proposed that
vault complexes might participate in drug resistance by their
influence on the lysosomal function (Herlevsen et al., 2007).
Interestingly, vaults disassemble into halves at low pH
(Goldsmith et al., 2007; Esfandiary et al., 2009). The possibility
of the acidic nature of lysosomes participating in the opening
of vault particles has still to be explored.
Their hollow structure, rapid movements and distinct
subcellular localization led to the hypothesis that vaults might
represent rather promiscuous transport vehicles (Steiner et al.,
2006). Recent experiments have shown that recombinant
vaults are also capable of half-vault exchange mechanisms in
vitro (Yang et al., 2010). These experiments indicate that vaults
are not rigid impenetrable boxes, but a fluctuating dynamic
structure presenting substantial flexibility. Furthermore, the
proposal that vaults could act as a cellular transporter implies
that these particles must present a highly regulated opening
mechanism in order to efficiently incorporate and deliver the
specific vault cargo. Even so, both the precise regulation of the
opening mechanism and the structural characteristics that can
allow such surprising dynamics still have to be clearly defined.
The X-ray structure of rat vault was solved to a resolution of
3.5 A˚ (Tanaka et al., 2009). It shows that the vault shell is
organized into two identical moieties, each consisting of 39
copies of MVP (Fig. 1a). Within the vault shell, MVP is
organized into 12 domains: nine structural repeat domains at
the N-terminus, followed by a shoulder / domain, a cap-
helix and a cap-ring at the C-terminus (Fig. 1b). In this
structure the initial phasing was achieved by density modifi-
cation, in particular using noncrystallographic symmetry
(NCS) averaging, starting from a cryo-electron microscopy
reconstructed model (Kato et al., 2008). Despite the strength
of averaging strongly supporting the similarity of all of the
MVP subunits, the 39 monomers contained in the crystal
asymmetric unit were independently built and explicitly used
during refinement. The relaxation of the 39-fold rotational
symmetry resulted in some movements and conformational
differences between MVP monomers and greatly increased
the number of degrees of freedom (Tanaka et al., 2009).
Almost in parallel, the 2.1 A˚ resolution structure of the seven
N-terminal repeat domains of MVP (R1–7), which form the
vault waist, was reported together with an independent
determination of the vault structure at 8 A˚ resolution, which
had again been phased by density modification with averaging
(Querol-Audı´ et al., 2009). The structures provided some hints
on the vault opening mechanism, showing that a combination
of electrostatic and hydrophobic interactions, mediated by R1
repeats, govern the association of the two half-vault moieties.
This observation led to the proposal of a reversible mechanism
of dissociation of the vault particle induced at acidic pH.
In this work, we have generated a new refined model of the
vault particle by incorporating the high-resolution structure of
the MVP N-terminal domain (R1–7; Querol-Audı´ et al., 2009)
into the 3.5 A˚ resolution model (Tanaka et al., 2009). A new
refinement of the vault structure was performed on a single
MVP subunit, strictly maintaining the 39-fold noncrystallo-
graphic symmetry. An extension of the deformable elastic
network (DEN) approach was employed, as included in the
low-resolution refinement package of CNS v.1.3 (Schro¨der
et al., 2010). The structural analysis of the refined vaults,
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Figure 1
Overall view of the vault structure refined using DEN protocols. (a) Half-vault structure (in beige) with one of the 39 MVP copies forming the particle
shown in blue. (b) Ribbon representation of one MVP monomer showing the overall fold. The 12 structural domains are explicitly labelled (sequence
numbering is shown for the starting and final residues of each domain). (c) Close-up of the cap-ring showing the superimposition of the new refined MVP
structure with the same part of subunit A from the structure with PDB code 2zuo (beige). (d) Close-up of the R1–2 repeats also showing the
superimposition of the two refined models of this MVP region.
facilitated now by having only one independent MVP subunit,
suggests that MVP can experience important movements at its
N-terminus during the closing of the two vault halves. It also
provides significant insights into the cap-ring architecture,
including a potential role in the binding of other vault
components and binding partners.
2. Materials and methods
2.1. Vault refinement using 39-fold symmetry and DEN
protocols
The MVP hybrid structure (residues 4–380 of PDB entry
3gnf plus residues 381–814 of PDB entry 2zv4) was refined
against the experimental structure factors from the work of
Tanaka et al. (2009) (PDB entry 2zv4). Refinement was
performed using an extension of the deformable elastic
network (DEN) approach included in the CNS v.1.3 package
(Schro¨der et al., 2010). During refinement, 39-fold noncrys-
tallographic symmetry (NCS) was always strictly maintained
with refinement parameters restricted to a single MVP subunit
and using the skew-matrix formalism also available in CNS.
2.2. The skew-matrix formalism
NCS position A01 is related to input coordinates A1
according to
A01 ¼ RA1 þ T;
whereR is a general rotation matrix, Ta translation vector and
the subscript 1 indicates the crystal reference frame.
The skew formalism firstly allows the oligomeric particle (in
our case the half vault) to be built in a standard orientation
where the NCS relations have simple forms, and secondly
positions the particle as a whole (the half vault) in its location
within the unit cell by a skew transformation that, in general,
corresponds to a skew rotation (matrix P) and a skew trans-
lation. In our case, with the vault half related by the crystallo-
graphic twofold at the y axis of a monoclinic space group, the
rotational axis of the particle passes through the origin;
consequently, translations, both in the standard and in the
crystal systems, are null and will be omitted.
Therefore,
A1 ¼ PA2;
where the subscript 2 indicates coordinates in the standard
orientation,
A02 ¼ UA2;
where U is an NCS rotational matrix in the standard orien-
tation,
A02 ¼ UP1A1;
A01 ¼ PA02 ¼ PUP1A1 ¼ RA1;
where R = PUP1.
2.3. The DEN protocol
A low-resolution refinement protocol based on the
deformable elastic network (DEN) approach (Schro¨der et al.,
2010) included in the CNS v.1.3 package was used. In this
protocol the model-refinement parameters are not the atomic
coordinates but the torsion angles, which reduces the number
of degrees of freedom by a factor generally larger than five.
The 39-fold noncrystallographic symmetry was strictly main-
tained during refinement with constraints applied to a single
MVP monomer, which was generated as a hybrid model
containing the R1–7 structure at the N-terminus (residues
Glu4–Val380) and coordinates corresponding to monomer A
of the deposited MVP model at the C-terminus (PDB entry
2zv4; residues Pro381–Gly814). The structural information
available for the R1–7 fragment was also used to increase the
amount of stereochemical data. This approach provided the
stability that the initial refinement attempts had been lacking,
with a reduction of about200 times (5 39) in the number
of degrees of freedom with respect to the published 3.5 A˚
vault structure and a significant increment in the number of
stereochemical restraints. The resulting low-resolution
refinement maps were often combined with averaging and
solvent-flattening processes.
2.4. Averaging and solvent flattening
Density averaging and solvent flattening were applied with
the program DM (Cowtan & Main, 1998) using the deposited
experimental data (PDB entry 2zv4) and different MVP
models for initial phasing.
The 39 original rotation matrices (in the standard orienta-
tion) multiplied by the skew matrix provided the 39 trans-
formations, all with null translations, required by DM. The
resulting maps allowed us to detect relatively important
changes in the domains of the R1–7 region between the
structures of the fragment and of the intact vault. Cycles of
CNS and DM were combined with manual model building
with Coot. To remove model bias, many different density-
modification processes were performed with starting phases
obtained from truncated models (for example, with only main
chain, without a specific repeat etc.).
2.5. Map sharpening
The contribution of the high-resolution diffraction data to
the electron density was enhanced by map sharpening, which
progressively up-weights the structure factors at increasing
resolutions by applying a negative Bsharp value to the experi-
mental amplitudes (Fobs) in a resolution-dependent weighting
scheme (Brunger et al., 2009),
Fsharpened ¼ exp½Bsharp sin2ðÞ=2Fobs;
where  is the Bragg angle and  is the wavelength.
Despite the fact that sharpening generally increases the
noise in the resulting electron-density maps, it appears this
can in turn be significantly reduced by density modification,
particularly by density averaging.
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3. Results and discussion
3.1. Generation of a new MVP vault particle model
To incorporate the high-resolution information available
from the R1–7 crystal structures (Querol-Audı´ et al., 2009)
into the structure of the vault, a preliminary hybrid model of
an MVP subunit was generated from the coordinates corre-
sponding to monomerA of the 3.5 A˚ resolution vault structure
(Tanaka et al., 2009; PDB entry 2zv4), in which the R1–7
repeats were replaced by the corresponding ones from the
R1–7 crystal structures (Querol-Audı´ et al., 2009). The three
crystal structures available for R1–7 (at 3.0, 2.5 and 2.1 A˚
resolution; PDB entries 3gng, 3gf5 and 3gnf, respectively;
Querol-Audı´ et al., 2009) presented almost identical confor-
mations except for a few residues at the N-terminus. There-
fore, the R1–7 model with the highest resolution (2.1 A˚),
which included residues Glu4–Val380, was used to replace the
R1–7 repeats. Each of the seven repeats was independently
superimposed as the largest differences were owing to changes
in their relative orientations, in particular for repeats R1, R2
and R7 (Querol-Audı´ et al., 2009). Superimpositions were
performed with LSQKAB from the CCP4 package (Winn et
al., 2011), except for repeats R1 and R2, which were super-
imposed using the molecular-replacement programMOLREP
(Vagin & Teplyakov, 2010) owing to large discrepancies in the
tracing and the lengths of the loops and in the assignment of
side chains when compared with those in the context of the
vault (Querol-Audı´ et al., 2009).
The resulting new model of the MVP subunit (including
residues Glu4–Gly814), with all of the atomic temperature
factors initially set to an arbitrary value (30 A˚2), was subjected
to refinement using the deposited 3.5 A˚ resolution experi-
mental data (Tanaka et al., 2009; PDB entry 2zv4), assuming
strict 39-fold noncrystallographic symmetry (NCS) for the
half-vault particle contained in the crystal asymmetric unit.
The complete vault particle was then obtained by the appli-
cation of a crystallographic twofold axis at the origin (mono-
clinic space group C2) that is coincident with one of the
particle twofold axes. In the first refinement step the whole
MVP subunit was treated as a single rigid body to overcome
any possible bias related to having arbitrarily chosen
monomer A from the 39 possible alternatives in the 3.5 A˚
resolution deposited vault structure (PDB entries 2zv4, 2zuo
and 2zv5). After convergence, different combinations of the
MVP domains were allowed to refine as independent rigid
bodies. The small distortions of connectivity introduced into
the model by the splitting into domains during the rigid-body
refinements were smoothed and regularized using Coot
(Emsley et al., 2010) and the regularize option of CNS
(Bru¨nger et al., 1998). During these refinements the 39-fold
noncrystallographic rotational symmetry was always strictly
maintained and fixed in the orientation that had been derived
previously during the vault structure determination: with the
39-fold rotational axis passing throughout the unit-cell origin
perpendicular to the crystal twofold b axis (y axis) and making
an ’ angle of 70.17 with respect to the unit-cell a axis (x axis)
(Tanaka et al., 2009). Once a model of the newMVP vault shell
was available the direction of the rotational axis was cross-
checked by a systematic search, obtaining slightly better
agreement values for a ’ value of 70.16 (Table 1). All of these
rigid-body refinements were facilitated by the skew-matrix
formalism available in CNS (see x2). This formalism allows the
vault particle to first be built in a standard orientation (chosen
here as that with the 39-fold rotational symmetry axis along
the unit-cell axis a, the x axis of the reference frame), where
the NCS relations have simple forms [here, pure rotations
around the x axis by angles n  (360/39), with n = 1, 2, . . . ,
39]. In a second step the vault is positioned in its true location
within the unit cell by a transformation including, in general, a
rotation (here around the y axis by angle ’) and a translation
(which is null here).
At the resolution available, maintaining strict NCS was
considered to be essential during refinement for both
conceptual and practical reasons. From the analysis of the
packing it was difficult to rationalize a systematic distortion of
the 39-fold NCS that could be well maintained in the mono-
clinic crystal, even more so as it seems to be a subtle distortion
at most and capable of retaining some of the twofold particle
symmetries as required by the coincidence with the crystal
twofold symmetry. Given the power of averaging and the
quality of the averaged maps, the expected differences
between MVP subunits should be, at 3.5 A˚ resolution, at most
very small. At this (low) resolution the number of degrees of
freedom approaches the number of reflections when explicitly
using the coordinates and temperature factors of the 39 MVP
research papers
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Table 1
Refinement of the orientation angle ’.
Angle ’ () 70.14 70.15 70.16 70.17 70.18
R factor 0.45721 0.45699 0.45693 0.45707 0.45778
Table 2
Refinement statistics of the vault model using strict 39-fold NCS
averaging: comparison with unrestricted refinement.
One MVP monomer
and 39-fold NCS
symmetry
39 MVP monomers
(Tanaka et al., 2009)
Resolution (A˚) 204–3.5 (3.63–3.50) 204–3.5
Reflections used 1441463† 1436395
No. of protein residues 796 31668
Rwork (%) 0.352 (0.488) 0.311
Rfree (%) 0.355 (0.474) 0.330
R.m.s.d. from ideal
Bond lengths (A˚) 0.003 0.010
Bond angles () 0.84 1.48
Ramachandran plot statistics (%)
Most favoured region 91.4 80.0
Additionally allowed region 8.4 18.3
Generously allowed region 0 1.4
Disallowed region 0.2‡ 0.3
Averaged B factors (A˚2)
Main chain 143.0 110.2
Side chain 145.5 133.1
Overall 144.2 121.4
† Reflections with [F/(F )] > 2.2 were used in the refinement for comparative
consistency with Tanaka et al. (2009). ‡ Corresponding to two proline residues located
in two exposed loops.
subunits contained in the crystal asymmetric unit. The
analysis, and even the handling, of a model containing 39 MVP
subunits is cumbersome, starting with the need for three
different PDB entries to store the coordinates. The quality of
the electron density obtained in this work upon application of
strict NCS provides additional validation of the procedure
used.
Refinement was continued with the refine protocols from
CNS v.3.1 using the deformable elastic network approach and
always maintaining strict NCS. The final refinement cycles
converged to an Rfree of 35% for 1 441 463 reflections
(Table 2). The fact that the new model gives a slightly higher
Rfree than the previous model (33%; Table 2) is not
surprising considering the enormous reduction in the number
of degrees of freedom in this new refinement
(from 960 942 parameters in the all-atom
refinement to 2955 parameters when using
torsional angles and strict NCS in the new
refinement protocol; see x2). The quality of
the final new model and the corresponding
refinement statistics are summarized and
compared with the available vault model in
Table 2. The electron-density maps were
further modified by enhancing the contri-
bution of the diffraction data at high reso-
lution by applying map sharpening with
Bsharp values lower than 60 A˚2 (Fig. 2).
Side chains and parts of MVP were removed
at different stages to monitor and minimize
model bias during sharpening (data not
shown).
3.2. Structural analysis
The resulting electron-density maps
present clear high-resolution secondary-
structure features (Figs. 2a and 2b).
However, density for R1, and to some extent
R2, is less well defined than for the
remaining repeats (Fig. 2c), which could be
related to the difficulties in tracing R1–2 in
the published 3.5 A˚ resolution vault struc-
ture and raises the possibility of some
disorder in the vault waist region, close to
the vault midsection, that could be blurring
the electron-density maps. Also, density for
the C-terminal part of the protein, after
Pro815, was difficult to interpret. The
description of the MVP subunit as consti-
tuted of ten globular domains (nine repeat
domains and a shoulder domain) and two
C-terminal nonglobular regions (a long cap-
helix and the cap-ring) remains fully valid in
the present refinement. In particular, from
R3 to the cap-helix the structure of the new
MVP model remains nearly identical to the
published structure (Tanaka et al., 2009),
although there are several sequence shifts
by one or a few positions in the R3–7 region.
Interestingly, the 2–3 loop of R7 is well
defined in the structure of the intact vault
but not in the R1–7 crystal structures. Re-
evaluation of the vault midsection, owing to
the retracing of R1 and R2, agrees with the
research papers
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Figure 2
Map sharpening enhances the high-resolution details of the maps. (a) Electron-density maps
(contoured at 2.5) before (green) and after (blue) map sharpening corresponding to the cap-
helix domain of the MVP (amino acids 728–741). Polypeptides are represented as sticks. (b)
Stereoscopic view of the electron-density map of repeat R6 (contoured at 2.5) after
refinement using DEN protocols. The structure of the repeat is depicted as ribbons, with some
of the side chains drawn as sticks. (c) Stereoscopic view of the electron-density map of repeat
R2 (depicted at the 1.3 level). Repeat R2 is shown as ribbons. Density at the vault mid-section
is less well defined than for the rest of the structure.
analysis that led us to propose a mechanism of dissociation of
the vault particle induced by a pH change (Querol-Audı´ et al.,
2009).
In the cap-ring the electron density first points towards the
rotational axis of the particle, while at the smallest radius
(25 A˚) it runs parallel to the axis (Fig. 1). Packing at this
small radius would allow at most 36 copies of parallel
-strands with a closest distance between adjacent strands of
4.5 A˚ (Figs. 3a and 3b). All of the prediction algorithms used
[T-Coffee (Notredame et al., 2000), JPred3 (Cole et al., 2008)
and ESPript (Gouet et al., 1999)] indicate the presence of a
conserved short -strand corresponding to the MVP sequence
Leu822–Leu825 in the cap-region. Similar sequences can be
found in at least 13 of the -strands forming the 16-stranded
parallel -sheet of the horseshoe-shaped (leucine-rich repeat)
ribonuclease inhibitor (Fig. 3c; PDB entry 1dfj; Kobe &
Deisenhofer, 1993). Therefore, a ring-like -sheet with 36
parallel strands was built at the vault inner cap-ring with the
guidance of the -sheet found in the ribonuclease inhibitor
structure (Fig. 3a). The three (or more) MVP subunits
excluded from the -sheet ring have to adopt alternative
conformations outside this inner cap-ring region. The possi-
bility of a compact structure not following 39-fold symmetry
(with 36, or maybe fewer, subunits) is compatible with the
presence in the cap of continuous electron density where
separation between subunits is not recognizable. The
numerous contacts between adjacent MVP subunits within the
half-vault could still guarantee the stability of the particle.
Moreover, MVP variants with C-terminal extensions produce
vault-like structures with the extensions pointing out of the
vault structure (Kickhoefer et al., 2009). In conclusion,
packing and electron-density maps strongly suggest that on
average one in every 13 MVP subunits presents an alternative
conformation outside the cap-ring.
3.3. Structural comparisons
Despite the overall similarity of the N-terminal repeats in
the new refined MVP model to those in the R1–7 crystal
structures, there are significant changes in the relative orien-
tations of the repeats with respect to each other, in particular
for R1–2, for R6 and for R7 (Fig. 4). On the other hand, the
orientations of the repeats remain essentially unchanged in
the three available R1–7 crystal structures, indicating that
these orientations are not determined by crystal-packing
interactions. Therefore, the different orientations of the
repeats in the MVP structure and in the R1–7 fragments
should be related to specific interactions in the vault that are
absent, or different, in the R1–7 fragments. The altered
environment at the C-end of the R1–7 fragment with respect
to an intact MVP subunit could explain, at least in part, the
large difference observed for the orientation of the R7 repeat,
which in turn also affects R6 and, to a lesser extent, R5 and so
on. In contrast, the different orientations of the N-end repeats
have to be a consequence of differences in the interactions
between neighbouring MVP subunits in the intact vault and in
the R1–7 crystals. In particular, interactions between the R1
repeats from the two vault halves are absent in the R1–7
crystals and could explain the large differences observed in
the orientations of the R1 and R2 repeats. What could the
biological implications of the N-terminus of MVP presenting a
twisted conformation in a vault environment with respect to
an isolated subunit be? The latest reviews of vault biology
have come to accept that this particle must have important
functions as an intracellular transport vehicle (Berger et al.,
2009; Steiner et al., 2006). Several proteins of considerable size
(PTEN, Erk etc.) have been identified as being bound and
some of them also as being transported by MVP (reviewed in
Berger et al., 2009). If these cargoes have to be protected in the
vault interior, an efficient mechanism of vault opening will be
required. Morever, vPARP has already been localized to bind
to the interior of the vault structure (Mikyas et al., 2004) and
can be incorporated into pre-formed vault-like structures
(Poderycki et al., 2006), indicating that this particle is not as
research papers
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Figure 3
(a) Representation of a possible arrangement of the cap-region with the
36-stranded -sheet inner ring (radius of 25 A˚) shown in blue and the
39 subunits in the outer part shown in beige. Therefore, three MVP
subunits appear to adopt alternative conformations avoiding the inner
ring (see text). (b) View of the continuous electron density that forms the
vault cap-ring. The tracing of only 13 chains is shown for clarity, with the
distance within strands explicitly labelled. (c) Sequence alignment of 13
-strands (from the 16 forming the parallel -sheet of the ribonuclease
inhibitor structure; PDB entry 1dfj) with the corresponding region of the
C-terminus of MVP. Residue numbers are indicated for each sequence
and the predicted -strand for MVP is drawn at the bottom.
hermetic as it might appear. The opening of the vault particle
might be triggered by molecular breathing (although this has
not yet been reported) or by an acidic pH inducing the
protonation of key acidic residues that could then initiate the
separation of the vault halves by charge repulsion (Querol-
Audı´ et al., 2009). In any case, the breakage of the midsection
contacts is now expected to trigger movement of the R1–2
repeats towards the orientation observed in the R1–7 frag-
ments, thus further facilitating the cooperative separation of
the two halves (Fig. 4b) as has been described to occur for the
vault particle (Yang et al., 2010).
The C-terminal region of the cap-ring, which presents a two-
layered density, remains difficult to interpret. Therefore, after
Pro815 the tracing with just C atoms indicates that the likely
chain path was retained (Tanaka et al., 2009). However, the
extended density joining the two layers corresponds very well
to a four-residue -strand that would form an intersubunit
parallel -sheet, likely corresponding to residues Leu822–
Leu825 (Fig. 3c). This would require small rearrangements in
the trace from Pro815 to Leu822 and would also imply that the
final C position corresponds to residue 829 (Fig. 1b). This
intersubunit parallel -sheet, which is likely to be formed by
only 36 strands, defines the narrowest radius (25 A˚) of the
MVP shell with respect to the central vault axis. It is inter-
esting to remark that in the ribonuclease inhibitor there is a
rim of exposed hydrophobic residues on the internal face of
the -sheet ring where ribonuclease binds (Kobe & Deisen-
hofer, 1993, 1995). In the -sheet ring of vaults a similar
exposed hydrophobic rim could be formed by Leu825 and be
directed towards the unexplained central density that might
correspond to a disordered TEP1 (Tanaka et al., 2009).
4. Conclusion
The precise analysis of the vault structure was complicated by
the presence of 39 independent MVP subunits with slightly
different conformations and interactions, with a total number
of 31 668 protein residues corresponding to 810 residues in
each of the 39 MVP subunits. The structural analysis of vaults
is now simplified by a model defined by one independent MVP
subunit and corresponding strict NCS-related molecules. This
analysis reveals that important movements occur at the
N-terminus of MVP during the closing of the two vault halves.
The analysis also predicts the breakage of the 39-fold
symmetry in the cap-region (residues 815–849). A plausible
conformation similar to that of the ribonuclease inhibitor
indicates that the cap-ring intersubunit parallel -sheet might
act as a switch to precisely define the number of MVP subunits
in a vault and as a potential binding site for the other vault
components and binding partners.
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Figure 4
The R1–7 region presents a more closed conformation in the vault
particle when compared with the R1–7 soluble domain. (a) Stereoview of
the superposition of repeat R7 in the structure of the R1–7 soluble
domain ring (blue) on the corresponding region within the vault (beige).
(b) A hybrid half-vault model generated by the superposition displayed
in (a) in the context of the vault particle is shown at the top and the usual
closed half vault is shown below.
(BFU2012-36827). Many thanks are given to the PDB for
valuable help during the validation process.
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